Microarray patches: potentially useful delivery systems for long-acting nanosuspensions

Research output: Contribution to journalReview article

16 Citations (Scopus)
157 Downloads (Pure)

Abstract

Long-acting drug nanosuspension formulations are coming to the fore as controlled release strategies for several medical conditions and as a preventative measure against HIV infection. However, such delivery systems must, by necessity, be given by hypodermic injection, typically into muscle. This poses problems for patients who are needle-phobic, given that injections have to be administered on a weekly or monthly basis. Needle-stick injuries, inappropriate reuse of needles, and poor disposal practices are major challenges in developing countries. Dissolving microneedles (MNs) are capable of delivering high drug doses, if suitably designed and formulated, and are also capable of delivering nanoparticles (NPs) into viable skin. Given that such microneedles are minimally invasive and self-disabling, the potential for major enhancement in patient care and compliance exists. In this review, we explore the key considerations in the development of these combination drug delivery systems.
Original languageEnglish
JournalDrug Discovery Today
Early online date23 Oct 2017
DOIs
Publication statusEarly online date - 23 Oct 2017

Fingerprint

Needles
Needlestick Injuries
Drug Compounding
Injections
Drug Delivery Systems
Patient Compliance
Nanoparticles
Developing Countries
HIV Infections
Patient Care
Muscles
Skin
Pharmaceutical Preparations

Keywords

  • long-acting drug nanosuspensions
  • microneedles
  • nanoparticles

Cite this

@article{691eb3b04eb24c50b800f99255aec76f,
title = "Microarray patches: potentially useful delivery systems for long-acting nanosuspensions",
abstract = "Long-acting drug nanosuspension formulations are coming to the fore as controlled release strategies for several medical conditions and as a preventative measure against HIV infection. However, such delivery systems must, by necessity, be given by hypodermic injection, typically into muscle. This poses problems for patients who are needle-phobic, given that injections have to be administered on a weekly or monthly basis. Needle-stick injuries, inappropriate reuse of needles, and poor disposal practices are major challenges in developing countries. Dissolving microneedles (MNs) are capable of delivering high drug doses, if suitably designed and formulated, and are also capable of delivering nanoparticles (NPs) into viable skin. Given that such microneedles are minimally invasive and self-disabling, the potential for major enhancement in patient care and compliance exists. In this review, we explore the key considerations in the development of these combination drug delivery systems.",
keywords = "long-acting drug nanosuspensions, microneedles, nanoparticles",
author = "Donnelly, {Ryan F.} and Eneko Larra{\~n}eta",
year = "2017",
month = "10",
day = "23",
doi = "10.1016/j.drudis.2017.10.013",
language = "English",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Microarray patches: potentially useful delivery systems for long-acting nanosuspensions

AU - Donnelly, Ryan F.

AU - Larrañeta, Eneko

PY - 2017/10/23

Y1 - 2017/10/23

N2 - Long-acting drug nanosuspension formulations are coming to the fore as controlled release strategies for several medical conditions and as a preventative measure against HIV infection. However, such delivery systems must, by necessity, be given by hypodermic injection, typically into muscle. This poses problems for patients who are needle-phobic, given that injections have to be administered on a weekly or monthly basis. Needle-stick injuries, inappropriate reuse of needles, and poor disposal practices are major challenges in developing countries. Dissolving microneedles (MNs) are capable of delivering high drug doses, if suitably designed and formulated, and are also capable of delivering nanoparticles (NPs) into viable skin. Given that such microneedles are minimally invasive and self-disabling, the potential for major enhancement in patient care and compliance exists. In this review, we explore the key considerations in the development of these combination drug delivery systems.

AB - Long-acting drug nanosuspension formulations are coming to the fore as controlled release strategies for several medical conditions and as a preventative measure against HIV infection. However, such delivery systems must, by necessity, be given by hypodermic injection, typically into muscle. This poses problems for patients who are needle-phobic, given that injections have to be administered on a weekly or monthly basis. Needle-stick injuries, inappropriate reuse of needles, and poor disposal practices are major challenges in developing countries. Dissolving microneedles (MNs) are capable of delivering high drug doses, if suitably designed and formulated, and are also capable of delivering nanoparticles (NPs) into viable skin. Given that such microneedles are minimally invasive and self-disabling, the potential for major enhancement in patient care and compliance exists. In this review, we explore the key considerations in the development of these combination drug delivery systems.

KW - long-acting drug nanosuspensions

KW - microneedles

KW - nanoparticles

U2 - 10.1016/j.drudis.2017.10.013

DO - 10.1016/j.drudis.2017.10.013

M3 - Review article

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

ER -